Alebund Pharmaceuticals

Shanghai, China · Founded 2018 · In IPO Registration

Operator of a biopharmaceutical company focusing on novel therapies discovery and development primarily for kidney diseases and their complications, as well as other chronic conditions. Alebund Pharmaceuticals is based in Shanghai, China and was founded in 2018. Its last reported valuation was $530 million in Oct 2025. It has raised $270 million.

Last reported valuation

$530.5M

Oct 2026

Priced at

—

Total raised

$269.8M

Last round

—

How much has Alebund Pharmaceuticals raised?

$269.8Macross 0 recorded rounds

Free account

More of Alebund Pharmaceuticals with a free account

·The complete investor list: 25 names
·Watch Alebund Pharmaceuticals: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Alebund Pharmaceuticals investors

25 investors are on record for Alebund Pharmaceuticals, including GIC Private, 5Y Capital, YuanBio Venture Capital and Tencent Investment. By type, the record holds 5 venture capital firms and 2 hedge funds.

For fundraisers

Raising for a company like Alebund Pharmaceuticals?

25 investors have backed Alebund Pharmaceuticals.

See all 25 investors →

Frequently asked about Alebund Pharmaceuticals

How much has Alebund Pharmaceuticals raised?: Alebund Pharmaceuticals has raised $269.8M in total across 0 recorded funding rounds.